---
title: "药物开发商 Generate Biomedicines 在美国首次公开募股（IPO）中筹集了 4 亿美元"
description: "2 月 26 日（路透社）- 药物开发公司 Generate Biomedicines 周四表示，它在美国首次公开募股中筹集了 4 亿美元，股票定价为每股 16 美元"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/277123859.md"
published_at: "2026-02-27T01:09:31.000Z"
---

# 药物开发商 Generate Biomedicines 在美国首次公开募股（IPO）中筹集了 4 亿美元

> 2 月 26 日（路透社）- 药物开发公司 Generate Biomedicines 周四表示，它在美国首次公开募股中筹集了 4 亿美元，股票定价为每股 16 美元

2 月 26 日（路透社）- 药物开发公司 Generate Biomedicines 周四表示，它在美国首次公开募股中筹集了 4 亿美元，股票定价为每股 16 美元。

### Related Stocks

- [NNNN.US - Anbio Biotechnology](https://longbridge.com/zh-CN/quote/NNNN.US.md)
- [FBT.US - 纽交所高增长板生物技术指数 ETF - First Trust](https://longbridge.com/zh-CN/quote/FBT.US.md)
- [PMCB.US - PharmaCyte Biotech](https://longbridge.com/zh-CN/quote/PMCB.US.md)
- [PBE.US - 动态生物技术与基因组 ETF - Invesco](https://longbridge.com/zh-CN/quote/PBE.US.md)
- [BIB.US - 2 倍做多纳斯达克生物技术 ETF - ProShares](https://longbridge.com/zh-CN/quote/BIB.US.md)
- [IBB.US - 纳斯达克生物科技指数 ETF - iShares Nasdaq](https://longbridge.com/zh-CN/quote/IBB.US.md)
- [BBH.US - 生物科技 ETF - VanEck Vectors](https://longbridge.com/zh-CN/quote/BBH.US.md)
- [XBI.US - 标普生物技术 ETF - SPDR](https://longbridge.com/zh-CN/quote/XBI.US.md)
- [SBIO.US - 医药突破 ETF - ALPS](https://longbridge.com/zh-CN/quote/SBIO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Alumis Shares Phase 3 Psoriasis Details, Targets 2H NDA Filing at Oppenheimer Healthcare Conference | Alumis (NASDAQ:ALMS) executives presented Phase 3 psoriasis results for envudeucitinib at the Oppenheimer Healthcare Con | [Link](https://longbridge.com/zh-CN/news/277123919.md) |
| Delcath Q4 revenue rises 37%, beats estimates | Delcath Systems reported a 37% increase in Q4 revenue, surpassing analyst expectations with $20.73 million. Despite a ne | [Link](https://longbridge.com/zh-CN/news/277046688.md) |
| BUZZ-Tevogen rises on plans to buy majority stake in digital health firm Sciometrix | Shares of drug developer Tevogen Biorise 13.7% to 33 cents premarketCo signs letter of intent to buy a majority stake in | [Link](https://longbridge.com/zh-CN/news/277058905.md) |
| 14:53 ETNuvia Dental Implant Center Named in Top10 Best Companies to Watch 2026 by BizTech Outlook | Nuvia Dental Implant Center has been recognized by BizTech Outlook as one of the "10 Best Companies to Watch 2026" for i | [Link](https://longbridge.com/zh-CN/news/277089366.md) |
| Gene testing firm Natera's Q4 revenue rises 39.8% | Gene testing firm Natera reported a 39.8% year-over-year increase in Q4 revenue, driven by product revenue growth and a  | [Link](https://longbridge.com/zh-CN/news/277101214.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。